title: Escherichia coli-Derived Uracil Increases the Antibacterial Activity and Growth Rate of Lactobacillus plantarum.
abstract: Lactobacillus plantarum (L. plantarum) is a representative probiotic. In particular, L. plantarum is the first commensal bacterium to colonize the intestine of infants. For this reason, the initial settlement of L. plantarum can play an important role in determining an infant's health as well as their eventual health status as an adult. In addition, L. plantarum combats pathogenic infections (such as Escherichia coli (E. coli), one of the early pathogenic colonizers in an unhealthy infant gut) by secreting antimicrobial substances. The aim of this research was to determine how L. plantarum combats E. coli infection and why it is a representative probiotic in the intestine. Consequently, this research observed that E. coli releases uracil. L. plantarum specifically recognizes E. coli-derived uracil, which increases the growth rate and production of antimicrobial substance of L. plantarum. In addition, through the inhibitory activity test, this study postulates that the antimicrobial substance is a protein and can be considered a bacteriocin-like substance. Therefore, this research assumes that L. plantarum exerts its antibacterial ability by recognizing E. coli and increasing its growth rate as a result, and this phenomenon could be one of the reasons for L. plantarum settling in the intestine of infants as a beneficial bacterium.
authors.affiliation: Department of Pharmacology, College of Pharmacy, Catholic University of Daegu, Gyeongsan 38430, Republic of Korea.
authors.forename: Eun-Mi
authors.initials: EM
authors.lastname: Ha
mesh_terms: D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000378:metabolism / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000737:chemistry / Q000187:drug effects / Q000494:pharmacology; D018533:Biomass; D019286:Endopeptidase K / Q000378:metabolism; D004926:Escherichia coli / Q000254:growth & development / Q000378:metabolism / Q000502:physiology*; D004927:Escherichia coli Infections / Q000517:prevention & control / Q000628:therapy; D007422:Intestines / Q000382:microbiology; D048191:Lactiplantibacillus plantarum / Q000254:growth & development / Q000378:metabolism / Q000502:physiology*; D056265:Microbial Interactions / Q000502:physiology; D050296:Microbial Viability / Q000187:drug effects; D019936:Probiotics / Q000378:metabolism / Q000494:pharmacology; D014498:Uracil / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D014498:Uracil; D019286:Endopeptidase K
keywords: Escherichia coli; Lactobacillus plantarum; antibacterial activity; growth rate; probiotics; uracil